About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Telehealth & HPV Self-Collection | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05089825

Telehealth & HPV Self-Collection

This study aims to compare the efficacy and participant experience of telehealth-based, self-collected cervical cancer screening to mail-based, self-collected cervical cancer screening across the adul...

Lead sponsor: OHSU Knight Cancer Institute•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

OHSU Knight Cancer Institute

Collaborators

Robert Wood Johnson Foundation
Oregon Health and Science University

This will be a prospective, randomized study of women ages 25 and older, stratified by menopausal status (defined as 12 months or greater without menses or time at which both ovaries have been surgically removed), who are eligible for cervical cancer screening.

Age

25 - 85 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Individuals with a cervix who are eligible for primary HPV testing (age 25 and older) according to national cervical cancer screening guidelines.
•Pregnant women are eligible for participation in this study as the collection process poses no threat to the woman or her fetus.

Exclusion Criteria

•Individuals without a cervix
•Have had prior pelvic radiation therapy or brachytherapy
•Active or former diagnosis of ovarian, uterine, or cervical cancer unless determined eligible by PI upon further review of history and treatment
•Individuals less than age 25 or no longer eligible/recommended to undergo cervical cancer screening
•Adults who are unable to consent or are decisionally impaired
•Individuals who are not English speaking

Related studies

CARE Tool Study Aim 3

NCT07296887 · Gynecologic Cancer, Prostate Cancer, and more

RECRUITINGPhase 2

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

NCT05787561 · Mesonephric Gynecologic Cancer

RECRUITINGPhase 1/2

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

NCT05559879 · Gynecologic Cancer, Carcinoma, and more

Avera Cancer Sequencing and Analytics Protocol (ASAP)

NCT05142033 · Cancer, Cancer Diagnosis, and more

RECRUITINGPhase 2

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

NCT07447050 · Breast Cancer, Sarcoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 16, 2023Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment131

Start dateJan 2022

Last updatedAug 16, 2023

Condition

Gynecologic Cancer

Locations shown

OHSU Knight Cancer Institute

Portland, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 16, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions